ARTIELLE IMMUNOTHERAPEUTICS
Artielle ImmunoTherapeutics, Inc., a biopharmaceutical company, develops recombinant T-cell receptor ligands (RTLs) to treat T-cell mediated inflammatory diseases. It develops RTL1000, a compound for the treatment of multiple sclerosis. The company focuses on the development of therapeutics for the treatment of autoimmune diseases that include multiple sclerosis, celiac disease, type 1 diabetes, rheumatoid arthritis, uveitis, stroke, optic neuritis, and other diseases. Artielle ImmunoTherapeutics, Inc. was founded in 2004 and is based in Tigard, Oregon.
ARTIELLE IMMUNOTHERAPEUTICS
Industry:
Biopharma Biotechnology Therapeutics
Founded:
2004-01-01
Address:
San Mateo, California, United States
Country:
United States
Website Url:
http://www.artielle.com
Total Employee:
1+
Status:
Active
Contact:
(650) 401-2000
Email Addresses:
[email protected]
Total Funding:
11.19 M USD
Technology used in webpage:
LetsEncrypt Apache PHP Parallels Plesk Panel
Similar Organizations
Anthos Therapeutics
Anthos Therapeutics is a biopharmaceutical company that specializes in the treatment of cardiovascular and metabolic diseases.
Current Employees Featured
Founder
Investors List
Northwest Technology Ventures
Northwest Technology Ventures investment in Series A - Artielle ImmunoTherapeutics
Tenex Greenhouse Ventures
Tenex Greenhouse Ventures investment in Series A - Artielle ImmunoTherapeutics
Sanderling Ventures
Sanderling Ventures investment in Series A - Artielle ImmunoTherapeutics
Pelion Venture Partners
Pelion Venture Partners investment in Series A - Artielle ImmunoTherapeutics
Official Site Inspections
http://www.artielle.com
- Host name: cust-155.130.138.26.switch.com
- IP address: 155.130.138.26
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
